Travere Therapeutics (TVTX) Loans and Notes Receivables (2015 - 2017)

Travere Therapeutics (TVTX) has 3 years of Loans and Notes Receivables data on file, last reported at $47.2 million in Q1 2017.

• For the quarter ending Q1 2017, Loans and Notes Receivables changed 0.0% year-over-year to $47.2 million; the trailing twelve-month figure through Mar 2017 stood at $47.2 million (changed 0.0% YoY), and the FY2016 full-year result was $46.8 million, changed 0.0% from the prior year.
• Loans and Notes Receivables for Q1 2017 stood at $47.2 million, up from $46.8 million in the prior quarter.
• Across five years, Loans and Notes Receivables topped out at $47.5 million in Q2 2016 and bottomed at $46.5 million in Q3 2015.
• The 3-year median for Loans and Notes Receivables is $46.8 million (2015), against an average of $46.9 million.
• Peak annual rise in Loans and Notes Receivables reached 0.0% in 2016, while the deepest fall reached 0.0% in 2016.
• A 3-year view of Loans and Notes Receivables shows it stood at $46.8 million in 2015, then changed by 0.0% to $46.8 million in 2016, then increased by 0.69% to $47.2 million in 2017.
• The last three Loans and Notes Receivables figures came in at $47.2 million (Q1 2017), $46.8 million (Q4 2016), and $46.5 million (Q3 2016), per Business Quant data.

Peer Comparison